Annual Review of Medicine

Papers
(The TQCC of Annual Review of Medicine is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-12-01 to 2024-12-01.)
ArticleCitations
The Gut–Brain Axis306
Phage Therapy for Antibiotic-Resistant Bacterial Infections277
mRNA Vaccines in the COVID-19 Pandemic and Beyond146
Hepcidin and Iron in Health and Disease131
The Role of Exercise in Management of Mental Health Disorders: An Integrative Review126
The Gut Microbiome and Inflammatory Bowel Diseases125
SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment114
Hepatocellular Carcinoma Immunotherapy104
Cardiovascular Effects of Particulate Air Pollution89
New Therapeutics for Ulcerative Colitis81
Engineering IL-2 to Give New Life to T Cell Immunotherapy80
Post-COVID-19 Condition80
Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches77
Diagnosis and Treatment of Helicobacter pylori Infection72
Whole Inactivated Virus and Protein-Based COVID-19 Vaccines71
Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies70
COVID-19 and Diabetes65
Clinical Perspectives on IgG4-Related Disease and Its Classification62
Hematopoietic Stem Cell Transplantation for Autoimmune Disease60
COVID-19: Inflammatory Profile58
Advances in Chronic Obstructive Pulmonary Disease58
Direct-to-Consumer Genetic Testing: Value and Risk56
COVID-19: Challenges of Viral Variants55
Synchronizing Brain Rhythms to Improve Cognition52
Microbiota Effects on Carcinogenesis: Initiation, Promotion, and Progression49
Cytokine Storm Syndrome49
New Therapeutics for Hepatitis B: The Road to Cure48
Contemporary Management of Thyroid Nodules44
COVID-19 Vaccines: Adenoviral Vectors44
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches43
Therapeutics Targeting Mutant KRAS43
Wearable Devices to Monitor and Reduce the Risk of Cardiovascular Disease: Evidence and Opportunities43
Aspirin in the Prevention of Colorectal Neoplasia42
Adeno-Associated Virus Gene Therapy for Hemophilia42
Hypoxia Reduction Sensitizes Refractory Cancers to Immunotherapy40
Benefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone40
Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome38
Toward Better Understanding and Management of CAR-T Cell–Associated Toxicity37
New Frontiers in Obesity Treatment: GLP-1 and Nascent Nutrient-Stimulated Hormone-Based Therapeutics36
0.023531913757324